PLIN5 and cardiac hypertrophy: DAPA mediated Plin5/PPAR-α signaling axis to reduce vascular endothelial growth factor-induced cardiac hypertrophy in vivo and in vitro [234, 235], while silting Plin5 can reverse the protective effect of this pathway [234].